B

Beryl Drugs Limited

BERLDRG
Market snapshot · 2026-08-11 10:36 UTC

24.00

₹-0.07 (-0.29%)

MARKET CAP

₹12.17 Cr

STOCK P/E

28.6x

52W HIGH

₹30.00

52W LOW

₹15.92

BOOK VALUE

₹19.51

EPS

₹0.84

ROE

4.38%

SECTOR

Health Care

DEBT/EQUITY

24.69

VOLUME

1,172

P/B RATIO

1.23x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹25.46₹23.70₹21.93₹20.17₹18.40VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 2.5% above historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.38). Confidence: 75%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Undervalued

5Y Average

24.56

Current

28.62

Overvalued

39.48

Undervalued

25.79

EV/EBITDA
Fair

5Y Average

5.08

Current

5.92

Overvalued

5.95

Undervalued

3.18

P/S
Overvalued

5Y Average

0.56

Current

0.65

Overvalued

0.64

Undervalued

0.47

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹5.47 CrMar 2026

Latest net profit

₹0.56 CrMar 2026

Latest EPS

₹1.10Mar 2026

Net margin

24.5%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-9.0%0.0%9.0%18.0%27.0%-2.00 Cr0.00 Cr2.00 Cr4.00 Cr6.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr2.00 Cr4.00 Cr6.00 Cr8.00 Cr₹-0₹0₹0₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr2.00 Cr4.00 Cr6.00 Cr8.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-6.00 Cr0.00 Cr6.00 Cr12 Cr18 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +6.098.188.097.663.216.295.645.405.224.835.163.855.47
Expenses +5.827.057.376.873.195.305.084.814.724.284.434.054.13
Operating Profit0.271.130.720.790.020.990.560.590.500.550.73-0.201.34
OPM %4.43%13.81%8.90%10.31%0.62%15.74%9.93%10.93%9.58%11.39%14.15%-5.19%24.50%
Other Income +0.000.000.000.000.000.000.000.000.000.000.000.000.00
Interest0.060.120.100.110.130.210.120.120.080.100.080.090.07
Depreciation0.150.280.290.310.320.280.330.310.320.380.390.320.40
Profit before tax0.060.730.330.37-0.430.500.110.160.100.070.26-0.610.87
Tax %-16.67%27.40%18.18%16.22%-16.28%26.00%90.91%62.50%-50.00%71.43%96.15%-72.13%34.48%
Net Profit +0.060.530.270.31-0.350.370.010.050.150.020.01-0.170.56
EPS in Rs0.121.050.530.61-0.690.730.020.100.300.040.02-0.341.10
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +26.38%26.38%26.38%27.48%27.82%
Public +73.61%73.62%73.62%72.53%72.19%
Others0.01%
Jun 2026
Promoters +
Public +

Events Timeline

Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June, 2026

Aug 05, 2026PDFCompany Reports Open

Intimation Regarding Temporary Unavailability Of The Company''s Website Due To An Unexpected Technical Issue

Jul 21, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 06, 2026PDFCompany Reports Open

Compliance-57 (5) : intimation after the end of quarter

Jul 06, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 30, 2026PDFCompany Reports Open